An Acupuncture Study for Breast Cancer Survivors With Joint Pain on Hormonal Therapies

Not Applicable

Recruiting

• Conditions: Breast Cancer; Breast Cancer Female; Breast Cancer Stage I; Breast Cancer Stage II; Breast Cancer Stage III; Breast Cancer Stage IIIB; Breast Cancer Stage IIIc; Breast Cancer, Male

• Registration Number: NCT06814977
• Lead Sponsor: Memorial Sloan Kettering Cancer Center

Brief Summary

The purpose of this study is to see whether acupuncture is a practical (feasible) treatment for breast cancer survivors with joint pain on hormonal therapies.

Detailed Description

Not available

Study Timeline

• Study Start: 2025-01-31
• Study First Submitted: 2025-02-03
• Study First Submitted QC: 2025-02-03
• Study First Posted: 2025-02-07
• Status Verified: 2025-05
• Last Update Submitted: 2025-05-21
• Last Update Posted: 2025-05-22
• Primary Completion: 2028-06-30
• Study Completion: 2028-06-30

Recruitment & Eligibility

• Status: RECRUITING
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

• English- or Spanish-speaking
• Black, Asian, and/or Hispanic women with a history of stage I, II, or III BC (transgender males are eligible to enroll)
• No evidence of current BC disease
• Receiving AI for at least 28 days with plan to continue for another 14 weeks
• Worst pain rated ≥4 on a 0-10 scale in the preceding week
• ≥15 days with pain in the past 30 days
• Pain lasting ≥1 month
• Pain attributed to AI as reported by the patient
• Willing and able to complete questionnaires and other study activities
• Willing and able to provide informed consent for the trial

Exclusion Criteria

• All Stage IV Cancer
• Active oncological disease
• Completed chemotherapy, surgery, or radiation <4 weeks prior to study
• Pain attributed to inflammatory arthritis (e.g., rheumatoid arthritis, gout)
• Procedures involving affected joints within the last month or planned in the next 14 weeks
• Acupuncture use for pain in the past year
• Implanted electronic device (e.g., pacemaker)

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Primary Outcome Measures

Name	Time	Method
Study feasibility as measured by rates of enrollment	1 year	The primary purpose of this study is to determine the feasibility of studying an acupuncture intervention for Aromatase inhibitor-associated arthralgias/AIA in racially/ethnically diverse, community-based breast cancer survivors.

Trial Locations

Locations (2)

Memorial Sloan Kettering Cancer Center (All protocol activites); 🇺🇸 New York, New York, United States

Jamaica Hospital Medical Center; 🇺🇸 Richmond Hill, New York, United States